The stock market rose modestly on Monday, continuing a recovery from a brief correction as investors focused on hopes for easing tensions between Ukraine and Russia.
The Dow Jones industrial average rose 16.05 points, or 0.10 percent, to close at 16,569.98, according to preliminary figures. The Standard & Poor's 500-stock index gained 5.33 points, or 0.28 percent, to 1,936.92. The Nasdaq composite index added 30.43 points, or 0.70 percent, to 4,401.33.
Consumer staples shares helped lead the market's gains, with a 0.8 percent increase for that sector. Among the better performing stocks was Sysco, a food services company, which rose 3.2 percent to $37.44 after its revenue exceeded expectations.
The gains were somewhat broad, with seven of the S.&P.'s 10 primary sectors moving higher. The rally extended gains from Friday, when the S.&P. 500 and Dow industrials posted their best day since March on news that Russia would cease military exercises near the Ukraine border.
The market seemed little affected by news that Russia would send an aid convoy to eastern Ukraine, a move that Western officials have said could serve as a pretext for an invasion. NATO's secretary general, Anders Fogh Rasmussen, warned that he still saw a "high probability" that Russia, using the guise of a humanitarian mission, could intervene militarily in Ukraine.
"From a fundamental standpoint, the big reason why we bounced back so sharply was because a big piece of geopolitical concern has been somewhat alleviated by the news of a Russia pullback," said Adam Sarhan, chief executive of Sarhan Capital.
"So far, the markets have been holding up pretty strong, with the bulls showing up last week and defending support levels," Mr. Sarhan said.
Stocks also climbed as the United States continued air strikes against Islamic State militants in northern Iraq over the weekend and as Israeli and Palestinian negotiators resumed talks mediated by Egypt on Monday.
Kinder Morgan jumped 9 percent to $39.37 after the energy company said on Sunday that it would put all its publicly traded units under one corporate roof in a $70 billion deal, an amount including $27 billion in assumed debt.
The company's other units — Kinder Morgan Partners, Kinder Morgan Management and El Paso Pipeline Partners — also rallied. The J.P. Morgan Alerian exchange-traded note tracking energy master limited partnerships rose 3.6 percent.
Shares of companies developing potential treatments for the Ebola virus rose amid growing calls to expedite research funding and drug approvals. Tekmira Pharmaceuticals surged 15 percent to $23.80 and Sarepta Therapeutics gained 7.4 percent to $22.66.
Allso up was the Priceline Group, which rose 2.2 percent to $1,309.28 after the company said quarterly revenue rose 26 percent.
Chiquita Brands International climbed 30.2 percent to $13.10 after the Cutrale Group, an orange juice supplier, and the Safra Group, an investment firm, offered to buy the company for $13 a share, or $611 million.
source : http://rss.nytimes.com/c/34625/f/640316/s/3d643d28/sc/2/l/0L0Snytimes0N0C20A140C0A80C120Cbusiness0Cdaily0Estock0Emarket0Eactivity0Bhtml0Dpartner0Frss0Gemc0Frss/story01.htm
Tidak ada komentar:
Posting Komentar